跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lamtac 50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lamtac 50
Approved
STANDARD
Lamtac 50
Intas Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f1d1b7d95e015897
Company
Intas Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
f1d1b7d95e015897
Drug Approval Philippines Name
Lamtac 50
Product Name
Lamtac 50
Registration Number
DRP-12394
Brand Name
Lamtac 50
Generic Name
Lamotrigine
Dosage Form
Tablet
Dosage Strength
50mg
Manufacturer
Intas Pharmaceuticals Limited
Importer
Accord Healthcare Limited - Philippine Branch Office
Company Detail Path
/organization/intas-pharmaceuticals-limited
Issuance Date
29 July 2022
Expiry Date
29 July 2027
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f1d1b7d95e015897
Type
Standard
Back to Philippines FDA Approvals